Evidence for aggregation-independent, PrP C -mediated Aβ cellular internalization
Year: 2020
Type: article
Abstract: Significance Amyloid β (Aβ) aggregation has been the therapeutic target of several Alzheimer’s disease (AD) clinical trials. Aβ exists in many different aggregated forms, making it exceedingly challenging to target. Evidence links intracellular Aβ accumulation and AD pathogenesis. We report that amino acids 1 to 30 of Aβ, Aβ (1–30), do not aggregate yet display cellular uptake stereospecificity when compared to its mirror image, suggesting that Aβ uptake is predominantly receptor-mediated and may be independent from its aggregation state. Additionally, we found Aβ (1–30) internalization to depend on PrP C expression. Aβ (1–30) thus represents a powerful tool to study mechanisms of Aβ cellular internalization and suggests that Aβ uptake could be modulated by therapeutically targeting high-affinity Aβ receptors.
Institution: University of California, Santa Cruz
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: University of California, Santa Cruz IMSD Program, Cyclic peptide permeability, Chiral Inactivation of Amyloid beta Actions in Cytotoxicity, Synaptic transmission and Plasticity, 800 MHz NMR Spectrometer and Helium Cryoprobe, Upgrade of a Pulsed Electron Paramagnetic Resonance Spectrometer, Discovering How Cu(II)/Zn(II) Uptake by the Prion Protein Controls Structure, Function and Neurotoxicity, UC Santa Cruz PREP
OpenAlex ID: W3095445698
